-
摘要: 目的:探讨凋亡相关蛋白Survivin及Bcl-2在鼻腔鼻窦鳞状细胞癌(SNSCC)中的表达及临床意义。方法:采用免疫组织化学Envision二步法检测35例SNSCC及20例正常下鼻甲黏膜标本中Survivin和Bcl-2的表达。结果:Survivin在SNSCC组织中的表达为88.6%,在正常下鼻甲黏膜组织无表达,二者差异有统计学意义(P<0.01)。Bcl-2在SNSCC组织中的表达为71.4%,明显高于正常下鼻甲黏膜组织的表达25%(P<0.01)。Survivin与Bcl-2的表达呈正相关(P<0.01)。肿瘤的分级程度越高,Survivin和Bcl-2的表达水平越低。结论:Survivin、Bcl-2与SNSCC的发生、发展有关,Survivin可能会成为SNSCC基因治疗的靶点。Abstract: Objective: To investigate the expression and it's clinical significance of Survivin and Bcl-2 in nasal squamous cell carcinoma(SNSCC).Method: The immunohistochemical Envision two step method was used to measure the expression of Survivin and Bcl-2 in 35 cases of SNSCC,20 cases of normal inferior concha tissues.Result: The expression of Survivin in SNSCC was 88.6%,significantly higher than the normal inferior turbinate mucosal tissue expression of 0%(P<0.01).The expression of Bcl-2 in SNSCC was 71.4%,significantly higher than the normal inferior turbinate mucosal tissue expression of 25%(P<0.01).Expression of Bcl-2 was significantly higher in SNSCC than in normal tissue. The expression of Survivin was positively correlated with Bcl-2 expression(P<0.01).The higher the grade of tumor, the lower expressions of Survivin and Bcl-2.Conclusion: Survivin and Bcl-2 may play an promoting role in the development and progression process of SNSCC. Survivin may become a target spot of SNSCC gene therapy.
-
Key words:
- nasal cavity /
- paranasal sinuses /
- carcinoma, squamous cell /
- Survivin /
- Bcl-2
-
[1] MAHALINGAPPA Y B,KHALIL H S.Sinonasal malignancy:presentation and outcomes[J].J Laryngol Otol,2014,128:654-657.
[2] ALTIERI D C.Targeting survivin in cancer[J].Cancer Lett,2013,332:225-228.
[3] DALLAGLIO K,PETRACHI T,MARCONI A,et al.Expression of nuclear survivin in normal skin and squamous cell carcinoma:apossible role in tumour invasion[J].Br J Cancer,2014,110:199-207.
[4] NECOCHEA-CAMPION R D,CHEN C S,MIR-SHAHIDI S,et al.Clinico-pathologic relevance of Survivin splice variant expression in cancer[J].Cancer Lett,2013,339:167-174.
[5] RÖDEL F,SPRENGER T,KAINA B,et al.Survivin as a prognostic/predictive marker and molecular target in cancer therapy[J].Curr Med Chem,2012,19:3679-3688.
[6] BOIDOT R,VÉGRAN F,LIZARD-NACOL S.Transcriptional regulation of the survivin gene[J].Mol Biol Rep,2014,41:233-240.
[7] CHEUNG C H,HUANG C C,TSAI F Y,et al.Survivin-biology and potential as a therapeutic target in oncology[J].Onco Targets Ther,2013,6:1453-1462.
[8] KANWAR R K,CHEUNG C H,CHANG J Y,et al.Recent advances in anti-survivin treatments for cancer[J].Curr Med Chem,2010,17:1509-1515.
[9] SHIN S,SUNG B J,CHO Y S,et al.An anti-apoptotic protein human survivin is a direct in inhibitor of caspase-3and caspase-7[J].Biochemistry,2001,40:1117-1123.
[10] CHEUNG C H,HUANG C C,TSAI F Y,et al.Survivin-biology and potential as a therapeutic target in oncology[J].Onco Targets Ther,2013,6:1453-1462.
[11] LINDSAY J,ESPOSTI M D,GILMORE A P.Bcl-2proteins and mitochondria-specificity in membrane targeting for death[J].Biochim Biophys Acta,2011,1813:532-539.
[12] AUTRET A,MARTIN S J.Emerging role for members of the Bcl-2family in mitochondrial morphogenesis[J].Mol Cell,2009,36:355-363.
计量
- 文章访问数: 26
- PDF下载数: 28
- 施引文献: 0